InDevR Archives | Be Korea-savvy
InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization

InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization

BOULDER, Colo., May 10 (Korea Bizwire) — InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced the commercial availability of its VaxArray® Pneumococcal Assay Kit for rapid and accurate assessment of pneumococcal vaccines at all stages of manufacturing, including multivalent drug product. This launch [...]

InDevR Launches ArrayMax Mixer for Even Faster VaxArray Assay Times

InDevR Launches ArrayMax Mixer for Even Faster VaxArray Assay Times

BOULDER, Colo., Nov. 16 (Korea Bizwire) — InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its new ArrayMaxTM Mixer to provide significantly reduced assay times for its VaxArray® Portfolio of immunoassay kits. Current VaxArray Assays include kits for influenza, coronavirus, measles/rubella, [...]

Now Available as Robust Flu Vaccine Potency Assay

Now Available as Robust Flu Vaccine Potency Assay

Flu-ToC is used as an alternative to single radial immunodiffision (SRID) for rapid quantification of influenza hemagglutinin protein in flu vaccines. (image: InDevR) BOULDER, CO, Oct. 22 (Korea Bizwire) – InDevR, a Boulder-based life science company, announced today that version 1.0 of Influenza Titer on Chip (Flu-ToC™) is now available for purchase as a complete kit.  Flu-ToC is [...]

InDevR Wins Barda Contract for Cutting-Edge Influenza Diagnostic

InDevR Wins Barda Contract for Cutting-Edge Influenza Diagnostic

BOULDER, CO, Sep. 16 (Korea Bizwire) - InDevR, a Boulder-based life science company, announced today that it has signed a contract (HHSO100201400010C) with the Biomedical Advanced Research and Development Authority (BARDA) to complete product development of their unique influenza diagnostic, FluChip-8G, which is capable of rapidly genotyping influenza viruses directly from clinical samples. The total contract [...]